QRX 0.00% 2.8¢ qrxpharma ltd

aust fin review article

  1. 52 Posts.
    Good to see John Holaday publicly saying he was 'gobsmacked' by the FDA decision last week.

    My concern is that again he appears to suggest that the FDA have got it wrong and it's only a matter of setting them straight on how good Moxduo is.

    I like his confidence but I get worred that perhaps he is telling SH what we want to hear. He's spent the last 2 years telling us how fantastic the product is and gave us some (to this point anyway) false hope.

    We'd better get it right next time.
 
watchlist Created with Sketch. Add QRX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.